World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
59
Citations
12423
World Ranking
10138
National Ranking
734

Frank Himmelsbach publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Frank Himmelsbach sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 346 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Frank Himmelsbach D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Frank Himmelsbach sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 59 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Frank Himmelsbach is affiliated with Boehringer Ingelheim in Germany. Their research primarily centers on chemistry, with a focus on organic and inorganic chemistry, alongside materials chemistry.

The main fields of study associated with their work include:

  • Chemistry

Within chemistry, their subfields of expertise are:

  • Organic Chemistry
  • Inorganic Chemistry
  • Materials Chemistry

Their research topics encompass several specialized areas:

  • Catalytic C-H Functionalization Methods
  • Radical Photochemical Reactions
  • Asymmetric Hydrogenation and Catalysis
  • Polyoxometalates: Synthesis and Applications

Frank Himmelsbach has co-authored work with the following researchers:

  • Christoph Nopper
  • Bernhard Breit
  • Nikolaus Müller
  • Beloslava Goycheva
  • Felix Bauer

Their recent publications include:

  • Photocatalytic synthesis of homoallylic amines via nucleophilic addition of nickel allyl complexes to imines, 2025, Chemical Science
  • O-p-Methoxyphenyl α-Hydroxycarboxylic Acids as Versatile Hydroxyalkylation Agents for Photocatalysis, 2024, Chemistry - A European Journal

The venues in which Frank Himmelsbach has published recent research are:

  • Chemical Science
  • Chemistry - A European Journal

Best Publications

  • BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.

    D Li;L Ambrogio;L Ambrogio;T Shimamura;S Kubo

  • Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker.

    Flavio Solca;Goeran Dahl;Andreas Zoephel;Gerd Bader

  • Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.

    R. Grempler;L. Thomas;M. Eckhardt;F. Himmelsbach

  • (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.

    Leo Thomas;Matthias Eckhardt;Elke Langkopf;Moh Tadayyon

  • 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes.

    Matthias Eckhardt;Elke Langkopf;Michael Mark;Moh Tadayyon

  • The p-nitrophenylethyl (NPE) group: A versatile new blocking group for phosphate and aglycone protection in nucleosides and nucleotides

    Frank Himmelsbach;Bernd S. Schulz;Thomas Trichtinger;Ramamurthy Charubala

  • 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments

    Frank Himmelsbach;Elke Langkopf;Matthias Eckhardt;Michael Mark

  • Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture

    Matthias Eckhardt;Peter Eickelmann;Frank Himmelsbach;Edward Leon Barsoumian

  • 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

    Frank Himmelsbach;Elke Langkopf;Matthias Eckhardt;Michael Mark

  • Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture

    Matthias Eckhardt;Frank Himmelsbach;Peter Eickelmann;Leo Thomas

  • Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

    Frank Himmelsbach;Michael Mark;Matthias Eckhardt;Elke Langkopf

  • Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture

    Matthias Eckhardt;Frank Himmelsbach;Peter Eickelmann;Achim Sauer

  • Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof

    Frank Himmelsbach;Matthias Eckhardt;Peter Eickelmann;Edward Leon Barsoumian

  • 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds

    Volkhard Austel;Helmut Pieper;Frank Himmelsbach;Guenter Linz

  • 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a ddp-iv inhibitor

    Frank Himmelsbach;Elke Langkopf;Matthias Eckhardt;Mohammad Tadayyon

  • Uses of DPP-IV inhibitors

    Klaus Dugi;Frank Himmelsbach;Michael Mark

  • Krystallinsk form av 1-klor-4-(B-D-glukopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloksy)-benzyl]-benzen, metode for fremstilling, samt anvendelse for fremstilling av medikamenter for behandling av sykdom

    Himmelsbach Frank;Eckhardt Matthias;Schmid Sandra;Schuehle Martin

  • Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof

    Frank Himmelsbach;Elke Langkopf;Birgit Jung;Stefan Blech

  • Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments

    Elke Langkopf;Matthias Eckhardt;Frank Himmelsbach;Mohammad Tadayyon

  • Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them

    Frank Himmelsbach;Elke Langkopf;Thomas Metz;Flavio Solca

Frequent Co-Authors

Matthias Eckhardt
Matthias Eckhardt Boehringer Ingelheim (Germany)
Herbert Nar
Herbert Nar Boehringer Ingelheim (Germany)
Wenjun Tang
Wenjun Tang Chinese Academy of Sciences
Chris H. Senanayake
Chris H. Senanayake TCG GreenChem Inc.
Christian Klein
Christian Klein Roche (Switzerland)
Matthew Meyerson
Matthew Meyerson Harvard University
Heidi Greulich
Heidi Greulich Broad Institute
Marisa C. Kozlowski
Marisa C. Kozlowski University of Pennsylvania
Robert F. Padera
Robert F. Padera Brigham and Women's Hospital
Lucian R. Chirieac
Lucian R. Chirieac Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various career paths across multiple industries. For those interested in law enforcement or legal support, pursuing a 2 year criminal justice degree online can complement a science background and lead to specialized roles.

Similarly, an associate degree in legal studies can pave the way to become a paralegal, where understanding legal protocols is crucial. Exploring paralegal salary associate's degree information helps gauge the financial benefits of entering this field with minimal schooling.

For Chemistry graduates interested in the pharmaceutical industry, becoming a drug representative is a popular option. Insights on the drug rep salary and career growth can inform decisions about this lucrative and dynamic role.

Those aiming for a more advanced clinical position might consider pursuing the extensive training required to become a pharmacist. Understanding how much schooling to be a pharmacist is essential for planning a long-term career in healthcare and pharmaceutical sciences.

Best Scientists Citing Frank Himmelsbach

Trending Scientists

Recently Published Articles